Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 3/16/14  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Marcia Keen

Wrong Dr. Marcia Keen?

Medical Research Senior Manager

Phone: (805) ***-****  HQ Phone
Local Address: Los Angeles, California, United States
Amgen Inc
One Amgen Center Drive
Thousand Oaks, California 91320
United States

Company Description: Amgen Inc. is a biotechnology company that discovers, develops, manufactures and markets human therapeutics-based on advances in cellular and molecular biology. The...   more
Background

Employment History

Education

  • PhD
  • MS
  • doctorate
    University of California , San Francisco
6 Total References
Web References
K/DOQI Update 2000
www.kidney.org, 27 Nov 2008 [cached]
,Marcia Keen, PhD, MS, RN, is Senior Manager, Nephrology professional Services at Amgen Inc. She has been actively involved in dialysis patient care and clinical research for a number of years. Her research interests have included quantification techniques for hemodialysis and peritoneal dialysis therapy, anticoagulation control in hemodialysis, and vascular access. Her published work includes book chapters and research reports in a number of professional journals. She is a member of the Steering Committee for the National Institutes of Health-sponsored HEMO trial. She was a member of the writing committee for the RPA Clinical Practice Guideline on Adequacy of Hemodialysis. She completed her doctorate at the University of California, San Francisco, in volume and osmolity control in hemodialysis patients.
QMS February 2010 Newsletter
qms-us.com, 1 Feb 2010 [cached]
It began with a discussion regarding Vascular Access by Dr. Marcia Keen, RN, PhD, CNN, Research Nurse at Ralph K. Davies Medical Center, San Francisco, as well as Amgen and project manager for The DOPPS study. Dr. Keen's session touched on the fact that the U.S. is behind most other countries in regards to the goals for the number of fistulas used as a primary access for dialysis patients, especially for patients starting dialysis. The effect of this has contributed to lower quality outcomes for U.S. patients including a higher mortality rate overall compared to the rest of the world as well as higher hospitalization rates. There are several aspects to this problem for the U.S. One is that because of the lack of insurance coverage for a large number of pre-ESRD patients many of them are not worked up prior to going on dialysis and consequently a fistula is not placed early. Another issue is that in comparison to other countries, U.S. vascular surgeons do not have extensive training or experience in fistula creation as is the case in other countries; this factor appears to be associated with high problem rates. Specific QCS reports were discussed in a workshop format to help attendees understand the data available in QCS to evaluate this issue in their clinics.
Following Dr. Keen's discussion, Diana Hlebovy, RN, BSN, CHN, CNN, Clinical Director of HemaMetrics, and a recognized expert on fluid management, discussed the rationale for emphasizing fluid management in the Conditions for Coverage.
QMS February 2010 Newsletter
www.qms-us.com, 1 Feb 2010 [cached]
It began with a discussion regarding Vascular Access by Dr. Marcia Keen, RN, PhD, CNN, Research Nurse at Ralph K. Davies Medical Center, San Francisco, as well as Amgen and project manager for The DOPPS study. Dr. Keen's session touched on the fact that the U.S. is behind most other countries in regards to the goals for the number of fistulas used as a primary access for dialysis patients, especially for patients starting dialysis. The effect of this has contributed to lower quality outcomes for U.S. patients including a higher mortality rate overall compared to the rest of the world as well as higher hospitalization rates. There are several aspects to this problem for the U.S. One is that because of the lack of insurance coverage for a large number of pre-ESRD patients many of them are not worked up prior to going on dialysis and consequently a fistula is not placed early. Another issue is that in comparison to other countries, U.S. vascular surgeons do not have extensive training or experience in fistula creation as is the case in other countries; this factor appears to be associated with high problem rates. Specific QCS reports were discussed in a workshop format to help attendees understand the data available in QCS to evaluate this issue in their clinics.
Following Dr. Keen's discussion, Diana Hlebovy, RN, BSN, CHN, CNN, Clinical Director of HemaMetrics, and a recognized expert on fluid management, discussed the rationale for emphasizing fluid management in the Conditions for Coverage.
K/DOQI Update 2000
www.kidney.org, 27 Nov 2008 [cached]
Marcia Keen, PhD, MS, RN, is Senior Manager, Nephrology professional Services at Amgen Inc. She has been actively involved in dialysis patient care and clinical research for a number of years. Her research interests have included quantification techniques for hemodialysis and peritoneal dialysis therapy, anticoagulation control in hemodialysis, and vascular access. Her published work includes book chapters and research reports in a number of professional journals. She is a member of the Steering Committee for the National Institutes of Health-sponsored HEMO trial. She was a member of the writing committee for the RPA Clinical Practice Guideline on Adequacy of Hemodialysis. She completed her doctorate at the University of California, San Francisco, in volume and osmolity control in hemodialysis patients.
NKF KDOQI Guidelines
www.kidney.org, 1 Jan 2000 [cached]
Marcia Keen, PhD, RN*
Other People with the name "Keen":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304